Bio Green Med Solution (BGMS) Accumulated Expenses (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Accumulated Expenses of $540000.0 for Q1 2026, down 1.64% year-over-year from $549000.0 in Q1 2025, and down 24.48% quarter-over-quarter from $715000.0 in Q4 2025.
Analysis
Bio Green Med Solution (BGMS) Accumulated Expenses (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Accumulated Expenses for 17 consecutive years, with $540000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses fell 1.64% year-over-year to $540000.0; the TTM figure through Mar 2026 stood at $540000.0 (down 1.64% YoY), while the FY2025 annual figure was $715000.0, down 57.16% from the prior year.
- Accumulated Expenses retreated to $540000.0 in Q1 2026 per BGMS's latest filing, from $715000.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $6.6 million in Q3 2023 and bottomed at $534000.0 in Q3 2025.
- Historically, Accumulated Expenses has averaged $2.8 million across 5 years, with a median of $2.9 million in 2022.
- Annual changes were most pronounced in 2023 — Accumulated Expenses surged 88.51% — and 2025, when it plunged 82.57%.
- Bio Green Med Solution's Accumulated Expenses stood at $5.0 million in 2022, then dropped by 6.71% to $4.6 million in 2023, then slumped by 63.86% to $1.7 million in 2024, then plunged by 57.16% to $715000.0 in 2025, then declined by 24.48% to $540000.0 in 2026.
- Business Quant data shows BGMS's Accumulated Expenses at $540000.0 in Q1 2026, $715000.0 in Q4 2025, and $534000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 503,000.00 |
| Mar 31, 2026 | 540,000.00 |
| Dec 31, 2025 | 715,000.00 |
| Sep 30, 2025 | 534,000.00 |
| Jun 30, 2025 | 539,000.00 |
| Mar 31, 2025 | 549,000.00 |
| Dec 31, 2024 | 1.67 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | 3.15 Mn |
| Dec 31, 2023 | 4.62 Mn |
| Sep 30, 2023 | 6.58 Mn |
| Jun 30, 2023 | 4.70 Mn |
| Mar 31, 2023 | 4.95 Mn |
| Dec 31, 2022 | 4.95 Mn |
| Sep 30, 2022 | 3.49 Mn |
| Jun 30, 2022 | 2.94 Mn |
| Mar 31, 2022 | 3.47 Mn |
| Dec 31, 2021 | 3.30 Mn |
| Sep 30, 2021 | 2.14 Mn |